These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35115535)

  • 1. Gαi2-induced conductin/axin2 condensates inhibit Wnt/β-catenin signaling and suppress cancer growth.
    Miete C; Solis GP; Koval A; Brückner M; Katanaev VL; Behrens J; Bernkopf DB
    Nat Commun; 2022 Feb; 13(1):674. PubMed ID: 35115535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy.
    Bernkopf DB; Brückner M; Hadjihannas MV; Behrens J
    Nat Commun; 2019 Sep; 10(1):4251. PubMed ID: 31534175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.
    Lustig B; Jerchow B; Sachs M; Weiler S; Pietsch T; Karsten U; van de Wetering M; Clevers H; Schlag PM; Birchmeier W; Behrens J
    Mol Cell Biol; 2002 Feb; 22(4):1184-93. PubMed ID: 11809809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2.
    Chen HY; Lang YD; Lin HN; Liu YR; Liao CC; Nana AW; Yen Y; Chen RH
    Sci Rep; 2019 Jul; 9(1):9687. PubMed ID: 31273221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative-feedback regulation of the Wnt pathway by conductin/axin2 involves insensitivity to upstream signalling.
    Bernkopf DB; Hadjihannas MV; Behrens J
    J Cell Sci; 2015 Jan; 128(1):33-9. PubMed ID: 25380820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle control of Wnt/β-catenin signalling by conductin/axin2 through CDC20.
    Hadjihannas MV; Bernkopf DB; Brückner M; Behrens J
    EMBO Rep; 2012 Apr; 13(4):347-54. PubMed ID: 22322943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
    Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
    Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability.
    Sun S; Gong YD; Kang JS; Dong MS; Choi Y
    Med Oncol; 2024 May; 41(6):147. PubMed ID: 38733492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
    Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
    Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
    Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
    Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.